Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgery,
Division of Urology,
Department of Surgery, Division of Urology
Joshua Ejdelman has not added Biography.
If you are Joshua Ejdelman and would like to personalize this page please email our Author Liaison for assistance.
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.
BMC cancer , 2012 | Pubmed ID: 23171135
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.
Translational oncology Dec, 2012 | Pubmed ID: 23401739
McGill University
Palak G. Patel1,2,
Shamini Selvarajah1,2,
Suzanne Boursalie1,2,
Nathan E. How1,2,
Joshua Ejdelman3,
Karl-Philippe Guerard3,
John M. Bartlett4,
Jacques Lapointe3,
Paul C. Park1,
John B. A. Okello1,2,
David M. Berman1,2
1Department of Pathology & Molecular Medicine, Queen's University,
2Division of Cancer Biology & Genetics, Queen's Cancer Research Institute, Queen's University,
3Department of Surgery, Division of Urology, McGill University,
4Transformative Pathology Program, Ontario Institute for Cancer Research (OICR)
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.